Answers are grounded in this paper and cite their sources.
Early stage detection of neurodegenerative diseases such as Alzheimer's disease (AD) is of utmost importance, as it has become one of the leading causes of death of millions of people. The gradual intellectual decline in AD patients is an outcome of fibrillation of amyloid beta 1-42 (Aβ₁₋₄₂) peptides in the brain. In this paper, we present localized surface plasmon resonance (LSPR) based sensing of Aβ₁₋₄₂ fibrillation using Au nano-urchins. Strongly localized field confinement at the spiky nanostructures of nano-urchin surfaces enables them to detect very low concentrations of Aβ₁₋₄₂. In addition, the LSPR peak of Au nano-urchins, which is very sensitive to ambient conditions, shows significant responses at different fibrillation stages of Aβ₁₋₄₂. Reduction in LSPR peak intensity with an increase in the fibrillation is chosen as the sensing parameter here. This paper in this context provides LSPR based highly sensitive, label-free and real-time sensing of Aβ₁₋₄₂ fibrillation that is highly advantageous compared to the existing techniques which require binding additives or fluorescent biomarkers.
No takes yet. Share an insight, caveat, or question.
Nair et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: